Shorts

0:39
Stop Assuming, Start Asking: Understanding the 'No'
6 hours ago
by
Narjust Florez, MD

0:43
Don’t Wait Until the Last Line to Consider Clinical Trials
2 days ago
by
Krish Patel, MD

0:47
Unlocking New Possibilities in Metastatic Breast Cancer Treatment
7 days ago
by
Komal Jhaveri, MD, FACP

0:30
Strategies for Sequencing Therapies in RCC
8 days ago
by
Daniel Heng, MD

0:46
CLL Outcomes Are Closing in on Age-Matched Controls
9 days ago
by
Jeff Sharman, MD

0:57
FDA Approval on the Horizon for Anito-cel in Multiple Myeloma
10 days ago
by
Matthew J. Frigault, MD, MS

1:00
Trispecifics Take T-Cell–Engaging Therapy a Step Further
14 days ago
by
Krish Patel, MD

0:37
Are KRAS Mutations More Common Than We Think?
14 days ago
by
Benjamin Herzberg, MD

0:15
2026 IMS Annual Meeting Highlights Across Myeloma
15 days ago

0:54
ASTRO 2026 Preview with Dr Raj Singh
19 days ago
by
Raj Singh, MD

0:35
Changing Treatment Paradigms in ROS1+ Lung Cancer
21 days ago
by
Jorge Nieva, MD

0:53
Why Community Cancer Centers Must Adapt to New Therapies
21 days ago
by
Andrew Dalovisio, MD

0:55
Why Radiation Therapy Hits a Wall
22 days ago
by
David DiBardino, MD

0:42
T-Cell Therapies Push Blood Cancer Treatment Forward
23 days ago
by
Krish Patel, MD

1:37
How Etentamig Stands Out From Other BCMA Bispecifics
a month ago
by
Peter Voorhees, MD

0:51
Why Do Promising Cancer Drugs Fail in Phase 3?
a month ago
by
David DiBardino, MD

0:31
Your Wednesday Oncology Wrap-Up - September 16
a month ago
by
Sabrina Serani

0:45
Unlocking HER2 Beyond Breast Cancer
a month ago
by
Aditya Shreenivas, MD, MS

0:39
MSOs: A Support System for Physicians
a month ago
by
Marcus Neubauer, MD

0:46
How AI Could Take the Guesswork Out of Payer Policies
a month ago
by
Marcus Neubauer, MD

0:31
Why No Oncologist Is Immune to Burnout
a month ago
by
Marcus Neubauer, MD

0:31
The Truth About Clinical Trial Enrollment
a month ago
by
Noelle Gillette Cloven, MD

0:34
Tackling the Health Care Interoperability Problem
a month ago
by
Marcus Neubauer, MD

0:31
The "Holy Grail" of Lung Cancer Surgery?
a month ago
by
Gavin M. Wright, MBBS, FRACS, PhD

0:42
Why Local Cancer Care Access is a Life-or-Death Issue
a month ago
by
Ryan Funk, MD

0:35
The EMR, AI, and the Fight Against Physician Burnout
a month ago
by
Marcus Neubauer, MD

0:43
Doing More With Less: The New Lung Surgery Challenge
a month ago
by
Gavin M. Wright, MBBS, FRACS, PhD

1:12
Upcoming Trials Could Bring New Drug Classes into Prostate Cancer
a month ago
by
Manojkumar Bupathi, MD, MS

0:35
Why Brain Cancer Treatment Feels Like a Rigged Marathon
a month ago
by
Clark Chen, MD, PhD

0:26
Your Wednesday Wrap-Up - September 2
a month ago
by
Sabrina Serani
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Breakthrough Status to Multi-Cancer Early Detection Blood Test
2
FDA Clears Phase 2 Trial of B7-H3 CAR T MT027 for Brain Metastases
3
As New TGCT Therapies Advance, Route, Duration, and Coverage Shape CSF1R Inhibitor Choice
4
Alpha-Emitting RYZ101 Meets Phase 3 PFS End Point in Advanced GEP-NETs
5
